IRhythm Technologies Debt to Equity Ratio 2015-2025 | IRTC
Current and historical debt to equity ratio values for IRhythm Technologies (IRTC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. IRhythm Technologies debt/equity for the three months ending June 30, 2025 was 6.25.
| IRhythm Technologies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $0.86B | $0.10B | 8.30 |
| 2025-03-31 | $0.84B | $0.09B | 9.69 |
| 2024-12-31 | $0.84B | $0.09B | 9.25 |
| 2024-09-30 | $0.84B | $0.07B | 11.68 |
| 2024-06-30 | $0.82B | $0.10B | 8.27 |
| 2024-03-31 | $0.82B | $0.09B | 9.08 |
| 2023-12-31 | $0.22B | $0.21B | 1.06 |
| 2023-09-30 | $0.22B | $0.22B | 1.00 |
| 2023-06-30 | $0.21B | $0.22B | 0.92 |
| 2023-03-31 | $0.20B | $0.22B | 0.90 |
| 2022-12-31 | $0.21B | $0.24B | 0.87 |
| 2022-09-30 | $0.20B | $0.24B | 0.84 |
| 2022-06-30 | $0.19B | $0.25B | 0.78 |
| 2022-03-31 | $0.18B | $0.25B | 0.75 |
| 2021-12-31 | $0.18B | $0.28B | 0.66 |
| 2021-09-30 | $0.18B | $0.30B | 0.62 |
| 2021-06-30 | $0.18B | $0.31B | 0.58 |
| 2021-03-31 | $0.17B | $0.31B | 0.55 |
| 2020-12-31 | $0.17B | $0.34B | 0.50 |
| 2020-09-30 | $0.16B | $0.34B | 0.49 |
| 2020-06-30 | $0.16B | $0.12B | 1.34 |
| 2020-03-31 | $0.16B | $0.13B | 1.26 |
| 2019-12-31 | $0.17B | $0.14B | 1.26 |
| 2019-09-30 | $0.17B | $0.14B | 1.18 |
| 2019-06-30 | $0.16B | $0.05B | 3.27 |
| 2019-03-31 | $0.07B | $0.05B | 1.36 |
| 2018-12-31 | $0.07B | $0.05B | 1.25 |
| 2018-09-30 | $0.06B | $0.06B | 0.86 |
| 2018-06-30 | $0.05B | $0.07B | 0.77 |
| 2018-03-31 | $0.05B | $0.07B | 0.68 |
| 2017-12-31 | $0.05B | $0.08B | 0.67 |
| 2017-09-30 | $0.05B | $0.09B | 0.57 |
| 2017-06-30 | $0.05B | $0.09B | 0.54 |
| 2017-03-31 | $0.04B | $0.09B | 0.49 |
| 2016-12-31 | $0.05B | $0.09B | 0.49 |
| 2016-09-30 | $0.05B | $-0.02B | -2.54 |
| 2016-06-30 | $0.04B | $-0.01B | -3.03 |
| 2016-03-31 | $0.00B | $0.00B | 0.00 |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | $0.00B | 0.00 |
| 2015-06-30 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.01B | $0.00B | 3.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.093B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.466B | 59.12 |
| Tempus AI (TEM) | United States | $12.696B | 0.00 |
| Doximity (DOCS) | United States | $11.914B | 53.01 |
| Hims & Hers Health (HIMS) | United States | $9.534B | 78.11 |
| Hinge Health (HNGE) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.663B | 39.16 |
| Privia Health (PRVA) | United States | $2.603B | 192.82 |
| Heartflow (HTFL) | $2.489B | 0.00 | |
| Enovis (ENOV) | United States | $1.740B | 9.20 |
| Phreesia (PHR) | United States | $1.681B | 0.00 |
| 10x Genomics (TXG) | United States | $1.669B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 28.24 |
| Schrodinger (SDGR) | United States | $1.428B | 0.00 |
| Azenta (AZTA) | United States | $1.388B | 60.58 |
| Clover Health Investments (CLOV) | United States | $1.292B | 0.00 |
| Claritev (CTEV) | United States | $1.115B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.660B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.568B | 0.00 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.347B | 0.00 |
| Carlsmed (CARL) | $0.333B | 0.00 | |
| TruBridge (TBRG) | United States | $0.293B | 51.40 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.137B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.119B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.086B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |